Global Healthcare-associated Infectious Disease Diagnostics Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Market Analysis by Infection Type
  • 1.3.1 Global Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Infection Type: 2020 VS 2026
  • 1.3.2 Urinary Tract Infections
  • 1.3.3 Surgical Site Infections
  • 1.3.4 Hospital-acquired Pneumonia
  • 1.3.5 BloodStream Infections
  • 1.3.6 Gastrointestinal Infections
• 1.4 Market by Application
  • 1.4.1 Global Healthcare-associated Infectious Disease Diagnostics Market Share by Application: 2020 VS 2026
  • 1.4.2 Hospitals
  • 1.4.3 Clinics
  • 1.4.4 ASCs
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Healthcare-associated Infectious Disease Diagnostics Market Perspective (2015-2026)
• 2.2 Healthcare-associated Infectious Disease Diagnostics Growth Trends by Regions
  • 2.2.1 Healthcare-associated Infectious Disease Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Healthcare-associated Infectious Disease Diagnostics Historic Market Share by Regions (2015-2020)
  • 2.2.3 Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Regions (2021-2026)
• 2.3 Healthcare-associated Infectious Disease Diagnostics Industry Dynamic
  • 2.3.1 Healthcare-associated Infectious Disease Diagnostics Market Trends
  • 2.3.2 Healthcare-associated Infectious Disease Diagnostics Market Drivers
  • 2.3.3 Healthcare-associated Infectious Disease Diagnostics Market Challenges
  • 2.3.4 Healthcare-associated Infectious Disease Diagnostics Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Healthcare-associated Infectious Disease Diagnostics Players by Market Size
  • 3.1.1 Global Top Healthcare-associated Infectious Disease Diagnostics Players by Revenue (2015-2020)
  • 3.1.2 Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Players (2015-2020)
• 3.2 Global Healthcare-associated Infectious Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Healthcare-associated Infectious Disease Diagnostics Revenue
• 3.4 Global Healthcare-associated Infectious Disease Diagnostics Market Concentration Ratio
  • 3.4.1 Global Healthcare-associated Infectious Disease Diagnostics Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Healthcare-associated Infectious Disease Diagnostics Revenue in 2019
• 3.5 Key Players Healthcare-associated Infectious Disease Diagnostics Area Served
• 3.6 Key Players Healthcare-associated Infectious Disease Diagnostics Product Solution and Service
• 3.7 Date of Enter into Healthcare-associated Infectious Disease Diagnostics Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Healthcare-associated Infectious Disease Diagnostics Breakdown Data by Infection Type

• 4.1 Global Healthcare-associated Infectious Disease Diagnostics Historic Market Size by Infection Type (2015-2020)
• 4.2 Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Infection Type (2021-2026)

5 Healthcare-associated Infectious Disease Diagnostics Breakdown Data by Application

• 5.1 Global Healthcare-associated Infectious Disease Diagnostics Historic Market Size by Application (2015-2020)
• 5.2 Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Healthcare-associated Infectious Disease Diagnostics Market Size (2015-2026)
• 6.2 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Infection Type (2015-2020)
• 6.3 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2015-2020)
• 6.4 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Healthcare-associated Infectious Disease Diagnostics Market Size (2015-2026)
• 7.2 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Infection Type (2015-2020)
• 7.3 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2015-2020)
• 7.4 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size (2015-2026)
• 8.2 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Infection Type (2015-2020)
• 8.3 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2015-2020)
• 8.4 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia

9 Latin America

• 9.1 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size (2015-2026)
• 9.2 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Infection Type (2015-2020)
• 9.3 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2015-2020)
• 9.4 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size (2015-2026)
• 10.2 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2015-2020)
• 10.3 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2015-2020)
• 10.4 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE

11Key Players Profiles

• 11.1 Abbott
  • 11.1.1 Abbott Company Details
  • 11.1.2 Abbott Business Overview
  • 11.1.3 Abbott Healthcare-associated Infectious Disease Diagnostics Introduction
  • 11.1.4 Abbott Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020))
  • 11.1.5 Abbott Recent Development
• 11.2 Accelerate Diagnostics
  • 11.2.1 Accelerate Diagnostics Company Details
  • 11.2.2 Accelerate Diagnostics Business Overview
  • 11.2.3 Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Introduction
  • 11.2.4 Accelerate Diagnostics Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
  • 11.2.5 Accelerate Diagnostics Recent Development
• 11.3 BD
  • 11.3.1 BD Company Details
  • 11.3.2 BD Business Overview
  • 11.3.3 BD Healthcare-associated Infectious Disease Diagnostics Introduction
  • 11.3.4 BD Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
  • 11.3.5 BD Recent Development
• 11.4 bioMrieux
  • 11.4.1 bioMrieux Company Details
  • 11.4.2 bioMrieux Business Overview
  • 11.4.3 bioMrieux Healthcare-associated Infectious Disease Diagnostics Introduction
  • 11.4.4 bioMrieux Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
  • 11.4.5 bioMrieux Recent Development
• 11.5 Bio-Rad
  • 11.5.1 Bio-Rad Company Details
  • 11.5.2 Bio-Rad Business Overview
  • 11.5.3 Bio-Rad Healthcare-associated Infectious Disease Diagnostics Introduction
  • 11.5.4 Bio-Rad Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
  • 11.5.5 Bio-Rad Recent Development
• 11.6 DiaSorin Molecular
  • 11.6.1 DiaSorin Molecular Company Details
  • 11.6.2 DiaSorin Molecular Business Overview
  • 11.6.3 DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Introduction
  • 11.6.4 DiaSorin Molecular Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
  • 11.6.5 DiaSorin Molecular Recent Development
• 11.7 F. Hoffmann-La Roche
  • 11.7.1 F. Hoffmann-La Roche Company Details
  • 11.7.2 F. Hoffmann-La Roche Business Overview
  • 11.7.3 F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Introduction
  • 11.7.4 F. Hoffmann-La Roche Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
  • 11.7.5 F. Hoffmann-La Roche Recent Development
• 11.8 Luminex
  • 11.8.1 Luminex Company Details
  • 11.8.2 Luminex Business Overview
  • 11.8.3 Luminex Healthcare-associated Infectious Disease Diagnostics Introduction
  • 11.8.4 Luminex Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
  • 11.8.5 Luminex Recent Development
• 11.9 Meridian Bioscience
  • 11.9.1 Meridian Bioscience Company Details
  • 11.9.2 Meridian Bioscience Business Overview
  • 11.9.3 Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Introduction
  • 11.9.4 Meridian Bioscience Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
  • 11.9.5 Meridian Bioscience Recent Development
• 11.10 OpGen
  • 11.10.1 OpGen Company Details
  • 11.10.2 OpGen Business Overview
  • 11.10.3 OpGen Healthcare-associated Infectious Disease Diagnostics Introduction
  • 11.10.4 OpGen Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
  • 11.10.5 OpGen Recent Development
• 11.11 QIAGEN
  • 10.11.1 QIAGEN Company Details
  • 10.11.2 QIAGEN Business Overview
  • 10.11.3 QIAGEN Healthcare-associated Infectious Disease Diagnostics Introduction
  • 10.11.4 QIAGEN Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
  • 10.11.5 QIAGEN Recent Development
• 11.12 Quidel
  • 10.12.1 Quidel Company Details
  • 10.12.2 Quidel Business Overview
  • 10.12.3 Quidel Healthcare-associated Infectious Disease Diagnostics Introduction
  • 10.12.4 Quidel Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
  • 10.12.5 Quidel Recent Development
• 11.13 Thermo Fisher Scientific
  • 10.13.1 Thermo Fisher Scientific Company Details
  • 10.13.2 Thermo Fisher Scientific Business Overview
  • 10.13.3 Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Introduction
  • 10.13.4 Thermo Fisher Scientific Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
  • 10.13.5 Thermo Fisher Scientific Recent Development
• 11.14 Trinity Biotech
  • 10.14.1 Trinity Biotech Company Details
  • 10.14.2 Trinity Biotech Business Overview
  • 10.14.3 Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Introduction
  • 10.14.4 Trinity Biotech Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
  • 10.14.5 Trinity Biotech Recent Development
• 11.15 Danaher
  • 10.15.1 Danaher Company Details
  • 10.15.2 Danaher Business Overview
  • 10.15.3 Danaher Healthcare-associated Infectious Disease Diagnostics Introduction
  • 10.15.4 Danaher Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
  • 10.15.5 Danaher Recent Development

12Analyst's Viewpoints/Conclusions

13Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer